SCHEMBL3267207

SCHEMBL3267207

CCOC(=O)Cc1cccc2c(=O)c3c(C)cc(C)c(C)c3oc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GLA P06280 2/20 0.53
▸ STING1 Q86WV6 1/20 0.53
▸ KDM4E B2RXH2 3/20 0.47
▸ CYP2D6 P10635 1/20 0.42
▸ PKM P14618 1/20 0.40
▸ HCAR2 Q8TDS4 1/20 0.38
▸ L3MBTL1 Q9Y468 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAOA P21397 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3271029 0.86 STING1 (0.71) GLASTING1KDM4ETDP1MEN1
SCHEMBL13395985 0.86 GLA (0.57) GLASTING1KDM4EMEN1KMT2A
SCHEMBL3267326 0.85 GLA (0.73) GLASTING1KDM4ECYP2D6PKM
SCHEMBL3273835 0.77 KDM4E (0.77) GLASTING1KDM4ECYP2D6PKM
SCHEMBL27900685 0.74 GLA (0.64) GLASTING1KDM4ECYP2D6ALDH1A1
SCHEMBL12677568 0.74 GLA (0.75) GLASTING1KDM4EALDH1A1MAPT
SCHEMBL3268787 0.74 GLA (0.54) GLASTING1KDM4EL3MBTL1ALDH1A1
Acetic Acid SCHEMBL3273667 0.73 GLA (0.44) GLASTING1MEN1KMT2AMAOA
SCHEMBL27860391 0.73 KDM4E (0.56) GLAKDM4EPKML3MBTL1ALDH1A1
SCHEMBL27900684 0.72 GLA (0.61) GLASTING1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8350065-B2 5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same GRAND PHARMA (CHINA) CO., LTD. (CN) 2013-01-08 — — US disclosed
US-8350065-B2 5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same GRAND PHARMA (CHINA) CO., LTD. (CN) 2013-01-08 — — US disclosed
US-8350065-B2 5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same GRAND PHARMA (CHINA) CO., LTD. (CN) 2013-01-08 — — US disclosed
EP-2196463-A1 PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, THE DERIVATIVES PREPARED AND PHARMACEUTICAL FORMULATIONS THEREOF Wuhan Grand Pharmaceutical Group Co., Ltd (CN) 2010-06-16 — — EP disclosed
EP-2196463-A1 PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, THE DERIVATIVES PREPARED AND PHARMACEUTICAL FORMULATIONS THEREOF Wuhan Grand Pharmaceutical Group Co., Ltd (CN) 2010-06-16 — — EP disclosed
US-20100099754-A1 5,6-DIMETHYL XANTHONE-4-ACETIC ACID DERIVATIVES AND METHOD OF PREPARING THE SAME GRAND PHARMA (CHINA) CO., LTD. (CN) 2010-04-22 — — US disclosed
US-20100099754-A1 5,6-DIMETHYL XANTHONE-4-ACETIC ACID DERIVATIVES AND METHOD OF PREPARING THE SAME GRAND PHARMA (CHINA) CO., LTD. (CN) 2010-04-22 — — US disclosed
US-20100099754-A1 5,6-DIMETHYL XANTHONE-4-ACETIC ACID DERIVATIVES AND METHOD OF PREPARING THE SAME GRAND PHARMA (CHINA) CO., LTD. (CN) 2010-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099754-A1 5,6-DIMETHYL XANTHONE-4-ACETIC ACID DERIVATIVES AND METHOD OF PREPARING THE SAME HCAR2, HAO2, HK2 GLA 2459/4885STING1 2933/4885KDM4E 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback